Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jakesz

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Dendritic cell-based vaccination in solid cancerA Stift, J Friedl, P Dubsky, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Anti-Cancer Drugs|November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancerT Brodowicz, R M Wolfram, W J Köstler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2006
Selective resection of colorectal liver metastasesD Tamandl, B Gruenberger, B Herberger, et al.
Endocrine-Related Cancer|March 26, 2003
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher, M Rudas, M Gnant, et al.
Wiener Klinische Wochenschrift|November 21, 1980
[Oestrogen receptors and prognosis in breast cancer]H Rainer, P Bettelheim, C Bieglmayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patientsD Kandioler-Eckersberger, C Ludwig, M Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger, R Bartsch, C Wenzel, et al.
Cancer Research|July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patientsM Müller, R M Mader, B Steiner, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Prognostic factors in the drug therapy of metastasizing breast cancer]R Mörz, M Schemper, P Bettelheim, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Dendritic cell-based vaccination in solid cancerA Stift, J Friedl, P Dubsky, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinomaG G Steger, M F Gnant, M P Djavanmard, et al.
Anti-Cancer Drugs|November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancerT Brodowicz, R M Wolfram, W J Köstler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2006
Selective resection of colorectal liver metastasesD Tamandl, B Gruenberger, B Herberger, et al.
Endocrine-Related Cancer|March 26, 2003
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher, M Rudas, M Gnant, et al.
Wiener Klinische Wochenschrift|November 21, 1980
[Oestrogen receptors and prognosis in breast cancer]H Rainer, P Bettelheim, C Bieglmayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patientsD Kandioler-Eckersberger, C Ludwig, M Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experienceG G Steger, R Bartsch, C Wenzel, et al.
Cancer Research|July 1, 1997
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patientsM Müller, R M Mader, B Steiner, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Prognostic factors in the drug therapy of metastasizing breast cancer]R Mörz, M Schemper, P Bettelheim, et al.
Pageof 19